新利luck18展位#104

药物代谢与药代动力学（DMPK）重要钻研药物的吸收、散布、代谢和渗出的动态过程与法规，评估药物的 DMPK特点对药物的前期开发和后期临床精准用药至关重要
。DMPK是桥接药理学、毒理学、药剂学、药物化学、甚至转化医学和精准医学的重要桥梁
。

第26届国际药物及化学异物代谢学会北美会议(ISSX)将于2024年9月15日至18日在美国夏威夷召开，会议内容涵盖药物代谢、药代动力学、临床药理学、生物分析和药物毒理学等领域
。国际药物及化学异物代谢学会(International Society for the Study of Xenobiotics，ISSX)是药物代谢钻研的最高学术组织之一，重要致力于全球领域内从事药物与化学异物代谢方面的学术互换和国际合作
。新利luck18受邀参与本次年会，新利luck18首创人&CEO陈春麟博士与新利luck18DMPK专家们等待与您相聚在104号展位
。

功夫 | 9.15-9.18
地址 | Hilton Hawaiian Village Waikiki Beach Resort, Honolulu
新利luck18展位  | 104，不见不散！

为了展示新利luck18创新实力和技术服务平台最新进展，新利luck18药代动力学/毒代动力学 (DMPK/TK) 掌管人蒋品博士将以海报 (Poster) 大局分享以下主题的杰出内容：
Title: Enhancing Drug - Drug Interaction Prediction by Integrating Physiologically- Based Pharmacokinetic Model with Fraction Metabolized by CYP3A4
Session Time: Wednesday, September 18, 2024 12:30?2:30 PM
Location: Poster Session 3
Poster Number: P270
Presenting Author: Dr. Pin Jiang, Senior Director of DMPK at Medicilon

ISSX现场新利luck18专家

Dr. Pin Jiang Senior Director of DMPK

Dr. Pin Jiang holds a Ph.D. from China Pharmaceutical University in collaboration with School of Pharmacy, Fudan University. Dr. Jiang is postdoctoral fellow in DMPK and Pharmacometrics at Fudan University, specializes in the development of DMPK/TK for innovative drugs. He has also published papers in international  journals such as DMD, EODMT, JSS and JPBA.

Having worked in the pharmaceutical R&D field for nearly 10years. Before joining Medicilon, Dr. Jiang held positions in the DMPK/TK and clinical pharmacology departments of well-known Biotech/Pharma/CRO companies (AstraZeneca Dizal Pharma, Covance, ChemPartner), focusing on small and large molecules. Dr. Jiang has been responsible for or involved in supporting hundreds of DMPK projects, including drugs, which have been approved by the Chinese NMPA and the US FDA for clinical research or market entry. 

Dr. Jiang also holds significant professional affiliations, serving as a youth committee member of the Drug Metabolism Committee of the Chinese Pharmacological Society (CSSX), a committee member of the Drug Metabolism Committee of the Shanghai Pharmacological Society, a youth committee member of the Pharmacology Committee of the Shanghai Pharmaceutical Association, and a member of the International Society for the Study of Xenobiotics (ISSX).

Business Communication
预约商务洽谈

Dr. Peggy Teng, Executive Director BD Operations

Dr. Karsten Holm, Director of Business Development

Dr. Mingzhu Zhang, VP of Business Development